MImAbs
Monoclonal antibody development
- B2B
About MImAbs
An innovative start-up specializing in developing monoclonal antibodies for cancer and inflammatory diseases for academic and pharmaceutical clients
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Marseille, Provence-Alpes-Côte d'Azur, France
- Founded
- 2012
- Revenue
- $5.7M – $45.2MTamtam estimate
- Website
- mimabs.org
- linkedin.com/company/mimabs
MImAbs at a glance
MImAbs is a B2B company in the Biotechnology Research industry, headquartered in Marseille, Provence-Alpes-Côte d'Azur, France.
MImAbs was founded in 2012.
MImAbs has 11–50 employees.
MImAbs's revenue is $5.7M – $45.2M (Tamtam estimate).
Selling to companies like MImAbs?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies